Fetal Alcohol Spectrum Disorders

C H A P T E R

3

Fetal Alcohol Spectrum Disorders: Effects and Mechanisms of Ethanol on the Developing Brain Marina Guizzetti O U T L I N E Introduction45

Mechanisms Involved in FASD 51 Gene–Ethanol Interactions 51 Neuronal Apoptosis 51 Glial Cells 52 Neuronal Plasticity 53 Neuroendocrine System 55 Epigenetics55 Oxidative Stress 56

Fetal Alcohol Spectrum Disorders (FASD)46 Fetal alcohol syndrome (FAS) 46 Partial (p)FAS 47 Alcohol-Related Neurodevelopmental Disorders (ARND) 47 Alcohol-Related Birth Defects (ARBD) 47 FASD Prevalence

48

Neurobehavioral Deficits in FASD

48

FASD and Brain Structures

48

Animal Models for FASD

50

Experimental Treatments for FASD

56

Acknowledgments58 References58

INTRODUCTION Ethanol exposure during gestation is associated with a variety of negative outcomes including reduced growth, cognitive dysfunctions, and behavioral deficits [1]. The fact that women who engage in heavy drinking give birth to problematic children has been known Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders http://dx.doi.org/10.1016/B978-0-12-800228-5.00003-0

45

© 2015 Elsevier Inc. All rights reserved.

46

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

since antiquity with references to it in the Bible, Aristotle’s work, documents from the Royal College of Physicians of London in 1726, and in an 1899 report from an English prison physician [2]. However, it was not until 1968 that the effects of drinking during gestation were first documented in the scientific literature following a French study [3]. Independently, another group in Seattle reported a similar phenotype in 11 children born to alcoholic mothers and introduced the term fetal alcohol syndrome (FAS) to describe this condition [4–6]. The studies from Jones and colleagues triggered a new and intense line of research aimed at characterizing, treating, and preventing the effects of ethanol in the developing brain. Alcohol exposure during gestation causes a continuum of effects in the offspring that are more severe in children with greater exposure [1]. However, even mild to moderate levels of in utero alcohol exposure have been associated with milder but similar central nervous system (CNS) dysfunction [7]. The United States Surgeon General (http://www.surgeongeneral.gov/news/2005/02/sg02222005.html) as well as other American health authorities advise pregnant women and women who may become pregnant to abstain from alcohol consumption. This chapter describes the main clinical, animal, and in vitro research on FASD with the intent of providing a picture of the body of knowledge currently available on the manifestations, diagnosis, and mechanisms involved in this devastating condition affecting individuals throughout life.

FETAL ALCOHOL SPECTRUM DISORDERS (FASD) Fetal alcohol spectrum disorders (FASD) are a group of conditions defined as the physical, behavioral, and learning sequelae that occur in the offspring of women who drank alcohol during pregnancy. However, the manifestations of the disorder display heterogeneity with the domains and severity of functioning or appearance differing greatly between individuals identified as having FASD [8,9]. Consequently, FASD is not a clinical diagnosis, rather, as defined by the Institute of Medicine (IOM) nomenclature, includes a variety of syndromes, such as fetal alcohol syndrome (FAS), partial FAS (pFAS), alcohol-related neurodevelopmental disorders (ARND), and alcohol-related birth defects (ARBD) [10,11].

Fetal alcohol syndrome (FAS) FAS is the first documented and most widely recognized consequence of prenatal alcohol exposure [6]. To render an FAS diagnosis, anomalies in three distinct areas need to be present: (1) growth retardation, (2) a distinct facial appearance, and (3) some evidence of a CNS dysfunction. Guidelines for FAS diagnosis have been published by the Centers for Disease Control and Prevention (CDC) [8] and the IOM [10,11]. In this section, we will refer to the CDC guidelines.

I.  NEURODEVELOPMENTAL DISORDERS

Fetal Alcohol Spectrum Disorders (FASD)

47

Growth retardation. Growth retardation can be pre- or postnatal and is defined as weight and/or height below the 10th percentile (after race, sex, and gestational age are considered). Distinct facial appearance. The three typical facial characteristics required for a FAS diagnosis are smooth philtrum, thin vermilion (upper lip), and short palpebral fissures [12]. Other facial characteristics are often present in individuals affected by FAS, including epicanthal folds, strabismus, ptosis, low nasal bridge, and ear anomalies, but are not required for the diagnosis. CNS dysfunction. Diagnostic criteria for FAS are either structural brain abnormalities or microcephaly (a head circumference at or below the 10th percentile) and neurological or functional deficits (e.g., global cognitive or intellectual deficits or functional deficits one standard deviation below the mean in at least three domains of functioning).

Partial (p)FAS Partial FAS diagnosis is described in the revised IOM guidelines. A diagnosis of pFAS is rendered when a confirmed history of maternal alcohol exposure, two of the facial characteristics, and either growth retardation or CNS dysfunction are present [10].

Alcohol-Related Neurodevelopmental Disorders (ARND) Shortly after the first characterization of FAS, it became apparent that FAS was not the only outcome of in utero alcohol exposure, but that cognitive and behavioral effects could be observed in individuals exposed to ethanol during gestation even in the absence of growth retardation and distinct facial appearance. To describe these effects of in utero alcohol exposure, the term ARND is currently used (previously called fetal alcohol effects). Because the characteristics of ARND (which include behavioral and cognitive effects similar to individuals with FAS, although in the absence of facial feature and growth retardation) are not unique to prenatal alcohol exposure, an ARND diagnosis is rendered only when prenatal alcohol exposure is confirmed. Furthermore, evidence of CNS damage defined as clinically significant structural, neurological, or functional impairment in three or more of the following domains, achievement, adaptive behavior, attention, cognition, executive functioning, language, memory, motor skills, multisensory integration, and social communication [13], need to be present for an ARND diagnosis [8,10].

Alcohol-Related Birth Defects (ARBD) Alcohol-related birth defects (ARBD) are congenital anomalies to the heart, kidney, skeleton, ears, and eyes, which are linked to maternal alcohol use. These anomalies may or may not be present in conjunction with CNS dysfunction. Maternal alcohol use during gestation needs to be confirmed for an ARBD diagnosis [8,11].

I.  NEURODEVELOPMENTAL DISORDERS

48

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

FASD PREVALENCE The CDC reported a prevalence of FAS ranging from 0.2 to two cases per 1000 births between 1993 and 2002 [8], whereas studies carried out in a similar time frame from others reported a prevalence between 0.5 and two cases in 1000 live births [14]. A more recent, mostly in-school, study found a prevalence of two to seven cases per 1000 live births in the USA [15]. In the same study, an FASD prevalence of 2–5% was found in younger schoolchildren in the USA and Western Europe [15]. The prevalence of FASD is not homogeneous across populations; for instance, an extremely high prevalence of FAS and pFAS, ranging from 68.0 to 89.2 per 1000 live births, was found in a region of South Africa characterized by low socioeconomical status, malnutrition, and a long history of wine production [16]. Among certain groups of Native Americans (Plains and Plateau culture tribes) an average FAS rate of nine per 1000 live births was reported [17].

NEUROBEHAVIORAL DEFICITS IN FASD Neurobehavioral deficits associated with heavy prenatal alcohol exposure include reduced IQ and impairments in several neurodevelopmental domains such as attention, reaction time, visuospatial abilities, executive functions, fine and gross motor skills, memory, language, and social and adaptive functions [18]. Children afflicted with neurobehavioral impairments may not have FAS facial features; however, these deficits in neurobehavioral functions are usually more severe in individuals with FAS facial features [19]. FAS is the leading preventable cause of mental retardation in the general population [20], although only 25% of individuals with FAS are officially mentally retarded (i.e., with an IQ lower than 70) [21]. The mean IQ in individuals with an FAS diagnosis and full FAS characteristics is estimated between 65 and 72, whereas the average IQ of individuals prenatally exposed to high levels of alcohol but without all the facial characteristics of FAS is about 80 [22]. In utero alcohol exposure is also associated with decreased academic achievement and increased learning disabilities [23], with verbal and nonverbal learning and memory impairment [24–26], and with visuospatial processing deficits [24]. FASD individuals present attention deficits and are often diagnosed with attention deficit hyperactivity disorder (ADHD) [27,28]. Examples of executive function deficits in FASD include problems with response inhibition, set shifting, planning, and concept formation [29,30]. Motor dysfunction such as tremors, weak grasp, poor hand/eye coordination, and gait and balance difficulties, which in heavily exposed individuals persists into adulthood, has also been documented [29,30].

FASD AND BRAIN STRUCTURES The facial dysmorphological characteristics of FAS are important because they are suggestive of brain abnormalities. Indeed, the symmetry of the forebrain and the symmetry of the face develop together during early embryogenesis between the fifth and the sixth week of gestation in humans. Insults affecting the development of the brain at this specific time result in alterations in the face as well as brain structures known as holoprosencephaly [31].

I.  NEURODEVELOPMENTAL DISORDERS

FASD and Brain Structures

49

Although the facial characteristics are the most apparent signs of heavy prenatal alcohol exposure, the most devastating consequences are due to brain abnormalities leading to behavioral dysfunction, which enormously impact individuals affected by prenatal alcohol exposure throughout their lives. Early studies based on autopsies reported general damage throughout most of the brain, microcephaly, migration abnormalities, agenesis of the corpus callosum and anterior commissure, heterotopias of neuroglia, and ventricle, brain stem, basal ganglia, and cerebellar anomalies [4,18]. It should be mentioned, however, that reports from autopsies represent only the most severe examples of in utero alcohol exposure, which are incompatible with life and therefore not necessarily representative of the brain abnormalities that occur in most individuals with FAS. Magnetic resonance imaging (MRI) followed by quantitative structural analyses consistently reported reduction of the cranial vault and the concomitant reduction in brain size in alcohol-exposed individuals, as reviewed in [18]. Cortical regions have been consistently found to be affected by in utero alcohol exposure. In the frontal, parietal, and temporal lobes less white matter, gray matter, and total lobe volume, higher gray matter density, thicker cortices, displacement, and reduced temporal asymmetry were reported. On the other hand, the occipital lobes appear to be relatively insensitive to the effects of prenatal alcohol. The effects of prenatal alcohol exposure on cortical structures may be responsible for impairments in verbal learning and recall, executive functions, language, and visuospatial processing in individuals with FASD [18,32,33]. Although one would expect the hippocampus to be affected by prenatal alcohol exposure based on commonly observed learning and memory impairments and depression in individuals with FASD, and because animal studies found hippocampal anomalies following developmental ethanol exposure, hippocampal-imaging studies have not revealed a consistent structural abnormality. Indeed, some studies report significantly smaller hippocampi after accounting for total brain volume, and other studies report significant differences only before correction. On the other hand, recent study reported an altered hippocampus shape in FAS children [34]. It has also been reported that, in some FASD cases, hippocampal volume unilaterally decreases, whereas the contralateral hippocampus is normal [18,32,33]. The cerebellum appears to be a major target of ethanol, and its volume and surface area have been found reduced in fetal alcohol exposed children with and without facial dysmorphology. The anterior vermis was found to be the most severely affected area of the cerebellum; in some cases, it was actually displaced. Domains of functioning found in children with FASD and associated with cerebellar anomalies include verbal learning and memory, balance, coordination, attention, and classically conditioned eye-blink learning [18,32,33]. Anomalies in the corpus callosum have been consistently found in subjects prenatally exposed to alcohol including agenesis, complete absence, hypoplasia, volume reduction, displacement, and increased variability of its shape [18,32,33]. Neurobehavioral functions altered in FASD and associated with the corpus callosum include motor function, attention, verbal learning, and executive function [33]. The basal ganglia and, in particular, the caudate nucleus appear to be especially sensitive to the effects of prenatal alcohol exposure, as their volume is reduced in children with FASD compared with controls. Because of basal ganglia connections with the motor and frontal cortex, deficits in executive and motor functions and coordination found in individuals with FASD can be ascribed at least in part to these consequences of prenatal alcohol exposure [18,32,33].

I.  NEURODEVELOPMENTAL DISORDERS

50

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

ANIMAL MODELS FOR FASD Animal studies have been instrumental to the understanding of the effects of ethanol on the developing brain. By far, the most used animal models in FASD research are rodents (mostly mice and rats). Interestingly, several neurobehavioral outcomes observed in individuals with FASD have been qualitatively reproduced in rodent models including learning, motor performance, inhibition, attention, and social deficits; behavioral effects in rodents were observed at blood alcohol concentrations that are achieved in humans [35-37]. Rodent studies also confirmed that ethanol exposure during brain development induced microcephaly [38] and affected the cerebral neocortex [39-43], the hippocampus [44], the cerebellum [45,46], the basal ganglia [47], and the corpus callosum [48-50]. To understand the timing of ethanol exposure used in rodent models of FASD, a comparison of the main stages of brain development in rodents and humans is provided. CNS development begins with the formation of the neural plate and continues through gestation and in the postnatal period in both humans and rodents. However, important events occurring during the third trimester of gestation in humans occur in rodents mostly postnatally (between gestational day (GD) 19 and postnatal day 10). CNS development is characterized by vulnerable periods during which exposure to teratogens may result in abnormalities specific to the ontogenic events occurring at the time of exposure [51]. Ethanol appears to interfere with all CNS developmental stages [45]. A first critical period of development is when organogenesis occurs and the neural tube and crest are formed; this occurs in rats between GD 5 and GD 11 and in humans in the first trimester of gestation [51]. Beginning in the second week of gestation in rodents (GD 7 in mice and GD 9.5 in rats) and the first month of gestation in humans, specific areas of the CNS begin to form with neurogenesis and migration of cells in the forebrain, midbrain, and hindbrain [51]. Mice exposed to ethanol during GD 7 or 8 exhibit the craniofacial anomalies associated with FAS, as well as forebrain deficiencies including hypoplasia or aplasia of the corpus callosum, and deficiency in the hippocampus and the anterior cingulated cortex, consistent with the holoprosencephaly spectrum of malformations [162]. In addition, prenatal exposure of primates to ethanol during this period reduces the number of neurons in the somatosensorymotor cortex [40]. The second critical period of development occurs in rats from GD 11–12 to GD 18–21, corresponding to the second trimester of gestation in humans [51]. During this time, most of the areas of the nervous system are differentiating; this phase is characterized by intense neurogenesis and neuronal migration in the cerebral cortex and hippocampus, two areas greatly affected by in utero alcohol exposure [45]. In rats, neurogenesis occurs prenatally in all brain regions, except for granule cells in the cerebellum and the dentate gyrus of the hippocampus. After neuroblast proliferation stops, differentiation of these cells into neurons and glia begins, followed by the development and elongation of processes that will become axons or dendrites in neurons. At this time of development, neurons from the cerebral cortex leave the germinal zone and migrate using radial glia fibers as scaffolds [51]. Ethanol exposure during this stage alters radial glia and depresses the generation, survival, and migration of neurons from the neocortex, hippocampus, and the principal sensory nucleus [39,41,42,52]. The last critical period in brain development occurs in rats from GD 18 to postnatal day 9 and is considered the equivalent of the third trimester in human gestation. Major events

I.  NEURODEVELOPMENTAL DISORDERS

Mechanisms Involved in FASD

51

during this period include a massive increase in brain size, proliferation of astrocytes and oligodendrocytes, myelination, synaptogenesis, and dendritic arborization [51]. Ethanol exposure during this developmental stage induces microcephaly [38], cerebellar [38] and hippocampal [53] abnormalities, severe apoptotic neuronal death in the hippocampus and cerebral cortex [54], reduced dendritic arborization [55-60], and behavioral dysfunctions [61]. Large animal models of FASD (including nonhuman primates and sheep) have also been developed. These models have the advantage of having longer gestations than rodents. In these models, the brain growth spurt occurs prenatally, similar to humans [62]. Other animal models used in FASD research include avian embryos [63], Drosophila [64], and zebrafish [65].

MECHANISMS INVOLVED IN FASD Gene–Ethanol Interactions Studies carried out in twins revealed that monozygotic twins exposed to ethanol during gestation have a 100% concordance for FAS diagnosis, whereas dizygotic twins displayed a 63% concordance [66,67]. This indicates that a certain degree of genetic susceptibility may underlie the FASD phenotype. Several human studies have shown an association between polymorphisms in the alcohol dehydrogenase 1B (ADH1B) gene and FASD. The product of the ADH1B gene encodes for the enzyme that catalyzes the first step of alcohol catabolism leading to the formation of acetaldehyde. The alleles ADH1B*2 or ADH1B*3 encode for proteins that are faster in metabolizing ethanol than the allele ADH1B*1. Most studies found an increased risk for FASD in individuals homozygous for ADH1B*1 and a protective effect of ADH1B*2 and ADH1B*3 [68-70]. Different animal species and strains were reported differentially susceptible to the teratogenic effects of ethanol, further supporting the notion of a degree of genetic predisposition to FASD. Animal studies identified several genes, in addition to ADH1B, that can potentially be involved in the genetic susceptibility to FASD, in particular with regard to facial dysmorphology, although further research in this area is necessary to validate these findings [71].

Neuronal Apoptosis It has been shown that the early postnatal period in rodents, corresponding to the third trimester of gestation in humans, is highly sensitive to the pro-apoptotic effects of ethanol on neurons [47]. In mice, exposure to high doses of ethanol on postnatal day 7 induces massive neuronal degeneration throughout the forebrain, midbrain, cerebellum, brain stem, spinal cord, and retina, which was demonstrated to be caused by apoptosis [47,54,72,73]. The effects of ethanol on neuronal apoptosis involve decreased expression of phosphorylated extracellular signal-regulated protein kinase (pERK), and the activation of the intrinsic mitochondrial pathway leading to mitochondrial damage [47]. Alcohol-induced activation of gamma-aminobutyric acid A (GABAA) receptors and inhibition of N-methyl-d-aspartate (NMDA) receptors are involved in ethanol-induced neuronal apoptosis in the developing brain [47].

I.  NEURODEVELOPMENTAL DISORDERS

52

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

The rodent cerebellum is also highly vulnerable to the effects of ethanol during the first 10 postnatal days [46]. At this developmental stage, Purkinje cells, which are generated prenatally, undergo massive dendritic outgrowth and synaptogenesis. On the other hand, cerebellar granule neurons, which are generated postnatally, are at an immature stage. Ethanol exposure during this time period reduces the number of both Purkinje and granule cells [74-77]. Cerebellar granule neurons, however, appear to be more sensitive to ethanol than Purkinje cells, particularly in the very early stage of their differentiation [76,78]. Mechanisms involved in the apoptotic effects of ethanol in cerebellar granule cells include interference with the antiapoptotic effects of glutamate NMDA receptor stimulation, interference with neurotrophic factors signaling (in particular insulin-like growth factor (IGF) I and II and brain-derived neurotrophic factor [BDNF]), activation of the intrinsic apoptotic signaling cascade, and induction of oxidative stress [46]. Early embryogenesis, before the onset of neurogenenesis, is another developmental stage highly sensitive to the apoptotic effects of ethanol. Indeed, exposure of mouse embryos to alcohol on GD 6.5–11, corresponding to the three to five weeks of human gestation, causes a marked increase in apoptotic degeneration of precursor cell populations of the developing brain and craniofacial region at developmental stages at which alcohol exposure affects concurrently the developing face, brain, eyes, and ear [79,80].

Glial Cells In the past several years, increasing attention has been devoted to the investigation of glial cell vulnerability to ethanol [81]. Several studies have shown that ethanol, both in vivo and in vitro, can significantly affect glial cells. Abnormalities in glial cell development are indeed suspected of contributing to the adverse effects of ethanol on the developing brain [82]. Abnormal glial migration in humans with FAS, as well as in primates and rats exposed to ethanol during development, has been reported [42,83]. A reduction in glial cell number has been reported in rat models of FAS [41,84]. In children with FAS, hypoplasia of the corpus callosum and anterior commissure, two areas originally formed by neuroglial cells, have been reported [85]. The finding that microencephaly is strongly associated with ethanol exposure during the brain growth spurt [86], a period characterized by rapid glial cell proliferation and maturation, also suggests a potential effect of ethanol on the proliferation, growth, and maturation of glia. Several studies also investigated the effects of ethanol on astrocytes and glial cell lines in culture. Prenatal alcohol exposure delays the expression of the astrocytic marker glial acidic fibrillary protein [81], and the incubation of primary astrocytes in culture with ethanol inhibits astrocyte proliferation induced by serum, M3 muscarinic receptor stimulation, and IGF-1 [87-89]. Our studies revealed a selectivity in the action of ethanol; indeed, we observed that muscarinic receptor-mediated activation of phospholipase C and subsequent increase in intracellular calcium levels, activation of novel protein kinase Cε, and of mitogen-activated protein kinases are relatively unaffected by ethanol [90-92]. On the other hand, phospholipase D-mediated formation of phosphatidic acid and sequential activation of atypical protein kinase Cζ, p70S6 kinase and of NF-κB, are all strongly inhibited by ethanol at concentrations of 25–50 mM [93-97].

I.  NEURODEVELOPMENTAL DISORDERS

Mechanisms Involved in FASD

53

Phospholipase D-induced phosphatidic acid formation was identified to be the direct target of ethanol in the inhibition of muscarinic receptor- and serum-stimulated signaling in astrocytes. Indeed, ethanol is a competitive substrate for phospholipase D leading to the formation of phosphatidylethanol instead of the physiological second-messenger phosphatidic acid [88,96,98]. Oligodendrocytes are glial cells that form myelin in the CNS. White matter abnormalities were reported in children and adolescents with FASDs [99]. In vivo studies have shown that prenatal alcohol exposure delays the expression of myelin basic protein and the maturation of oligodendrocytes, causing ultrastructural damage of the myelin sheaths, and reduces the number of myelinated axons in the optic nerve [81]. Recently, widespread oligodendrocyte apoptosis has been reported in the white matter regions of the fetal brain of monkeys exposed to high alcohol levels during the equivalent of the third trimester of human gestation [100]. Upon activation, microglia express and release inflammatory cytokines (TNFα, IL1β) and reactive oxidative species (NO, superoxide) leading to neuroinflammation, which contributes to several neuropathological conditions. Evidence exists that microglial cells can be directly activated by alcohol [101], that microglia-released factors contribute to ethanol-induced apoptosis in developing hypothalamic neurons [102,103], and that ethanol causes microglia cell death [104].

Neuronal Plasticity Several paradigms of neuronal plasticity are affected by alcohol exposure during brain development in animal models of FASD. Impaired long-term potentiation and long-term depression [105-108], learning and memory abilities [44,109-112], barrel cortex plasticity [113], ocular dominance plasticity [114,115], and eye-blink conditioning [116,117] were observed in animal models of FASD. A large body of evidence suggests that structural plasticity is highly affected by in utero alcohol exposure. Indeed, some cortical maps are altered in FASD models [118-120]. Furthermore, prenatal and/or neonatal alcohol exposure reduced dendritic branching and dendritic spines density of pyramidal neurons in the hippocampus and neocortex. Dendritic spine morphology was also affected by alcohol exposure during brain development [55-60]. Furthermore, several abnormalities were identified in neurite outgrowth of neurons exposed to ethanol in vitro [121-125]. One important mechanism involved in ethanolinduced inhibition of neurite outgrowth is the inhibition of L1 cell adhesion molecules [121,122,125-127]. Recent studies have investigated the effect of ethanol on neuronal plasticity modulated by astrocytes in vitro. Neuritogenesis is inhibited in cortical neurons grown in the presence of astrocytes prepared from rats prenatally exposed to ethanol in comparison to neurons incubated with astrocytes from unexposed animals [128]. Ethanol also inhibits axonal growth of cerebellar neurons induced by the active fragment of the astrocyte-released activity-dependent neuroprotective protein [129]. In addition, we have recently reported that the stimulation of muscarinic receptors in astrocytes induces neuritogenesis in hippocampal neurons cocultured with prestimulated astrocytes [130], and that this effect is inhibited by physiologically relevant concentrations of

I.  NEURODEVELOPMENTAL DISORDERS

54

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

ethanol [131]. Ethanol-treated astrocytes also displayed a reduced ability to foster neurite outgrowth when neurons are plated on top of ethanol-treated astrocytes [132]. We also found that ethanol profoundly affects astrocyte secretion leading to the generation of an environment that inhibits neuronal development. Indeed, ethanol reduced the levels of neuritogenic extracellular matrix proteins laminin and fibronectin through the modulation of the plasminogen activator proteolytic system [131,133]. Ethanol also increased the levels of the chondroitin sulfate proteoglycan neurocan, an inhibitor of neurite outgrowth, through the inhibition of the activity of arylsulfatase B, an enzyme involved in the degradation of chondroitin-4-sulfate [132]. Figure 3.1 schematically summarizes our findings.

FIGURE 3.1  Proposed mechanism of ethanol-treated astrocyte-induced inhibition of neurite outgrowth. The stimulation of M3 muscarinic receptors in astrocytes increases the release of fibronectin and laminin and of the inhibitor of ECM degradation PAI-1, therefore inducing neuritogenesis (A). Ethanol, by inhibiting muscarinic signaling, inhibits the release of fibronectin, laminin, and PAI-1. Furthermore, ethanol in astrocytes increases the expression and release of tPA which promotes the degradation of neuritogenic ECM, through the inhibition of DNMT activity andof DNA methylation in the tPA promoter region. Ethanol also inhibits ARSB activity and increases the levels of inhibitorychondroitin-4-sulfate (C4S) and the chondroitin sulfate proteoglycan neurocan (B). All together, these mechanisms contribute to the inhibition of ethanol-treated astrocyte-induced neurite outgrowth.

I.  NEURODEVELOPMENTAL DISORDERS

Mechanisms Involved in FASD

55

Neuroendocrine System In rodents, gestational and early postnatal ethanol exposures affect hypothalamic– pituitary–thyroid functions; indeed, decreased levels of circulating 3,5,3’-triiodothyronine (T3) and thyroxine (T4) and increased levels of thyroid-stimulating hormone were reported [134,135]. Prenatal alcohol exposure also increases the tone and dysregulates the hypothalamic–pituitary–adrenal axis throughout life, resulting in abnormally elevated responsiveness to stressors quantifiable biochemically and behaviorally; these effects of prenatal alcohol are often sexually dimorphic. These developmental effects of alcohol have been associated with increased depression and anxiety disorders observed in individuals affected by FASD [136,137].

Epigenetics The term “epigenetics” describes mechanisms of gene expression regulation independent from coded DNA sequences that rely, instead, on modifications of histones, DNA, or RNA. Acetylation and methylation are two major epigenetic histone modifications; the best-characterized DNA modification is cytosine methylation; epigenetic changes of RNA are associated with the silencing of posttranscriptional RNA [138]. A delay in the DNA methylation program associated with a delay in growth, decreased promoter methylation, and increased expression of genes involved in development was reported in mouse embryo cultures exposed to ethanol during neurulation. Effects similar to the ones induced by ethanol were also observed after treating embryo cultures with an inhibitor of DNA methylation [139,140]. Alcohol also decreased DNA methylation, increased expression of genes involved in development, and inhibited migration and differentiation of neural stem cells in vitro [141]. It has been recently reported that prenatal ethanol modulates DNA methylation and histone acetylation and affects the expression of the proopiomelanocortin gene in hypothalamic neurons; gestational choline supplementation normalizes these effects of ethanol [142]. An increase in global DNA methylation in the prefrontal cortex and hippocampus of postnatal day 21 rats exposed to ethanol between postnatal days 4 and 9 was recently reported [143], whereas combined pre- and postnatal alcohol exposure resulted in a significant increase in DNA methyltransferase activity on postnatal day 21 [144]. In astrocyte cultures, ethanol decreases DNA methyltransferase (DNMT) activity and DNA methylation in the promoter region of tissue plasminogen activator (tPA), thereby increasing tPA expression [133]. Increases in tPA levels lead to increased activation of the proteolytic enzyme plasmin potentially contributing to the observed ethanol-induced decrease in neuritogenic extracellular matrix proteins [131]. A high dose of ethanol administrated on postnatal day 7 increases histone 3 lysine 9 and histone 3 lysine 27 dimethylation, which are associated with transcription silencing, and induce robust apoptotic neurodegeneration, whereas pharmacological inhibition of histone dimethylation prevents ethanol-induced neurodegeneration [145], indicating an involvement of epigenetic histone modifications in the developmental effects of alcohol.

I.  NEURODEVELOPMENTAL DISORDERS

56

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

MicroRNAs (miRNAs) are members of the larger family of nonprotein-coding RNA molecules regulating gene expression. MicroRNAs pair with complementary sequences in mRNAs silencing their translation and triggering their degradation. Ethanol suppressed the expression of four miRNAs (miR-9, miR-21, miR-153, and miR-335) in fetal neural stem cells (NSCs) and neural progenitor cells (NPCs) of the neuroepithelium, and increased the expression of proteins involved in the premature differentiation of NSC/NPC cells [146]. Suppressed expression of miR-9 and miR-153 miRNAs was confirmed in a zebrafish model during embryonic development, and these effects of ethanol were associated with craniofacial alterations and increased locomotor activity (hyperactivity), two hallmarks of FAS [147,148]. In an FAS mouse model, ethanol induced miR-10a and miR-10b expression and inhibited the expression of Hoxa1, a gene associated with craniofacial defects and mental retardation [149]. Changes in several miRNAs were also observed after chronic ethanol exposure and ethanol withdrawal in cortical neuron cultures [150]. Together, these published data suggest that miRNAs may play a major role in the facial feature and behavioral dysfunctions observed in FASD [151].

Oxidative Stress Oxidative stress, which has been involved in the action of several teratogens, plays a role also in the effects of ethanol on the developing brain [152]. Gestational exposure to ethanol in rats and mice induced oxidative stress evidenced by increase lipid peroxidation, decreased levels of glutathione (GSH) and superoxide dismutase, and mitochondrial dysfunction. Oxidative stress after developmental alcohol exposure has been reported in the whole brain and in several brain regions, such as hippocampus, hypothalamus, and cerebellum. These effects can be long-lasting, and may lead to increased cell death and impaired neuronal plasticity [153-158]. Neonatal exposure of rodents to ethanol has also been shown to alter the GSH content and to increase the levels of lipid peroxides and protein carbonyls in several brain regions, effects that may cause cell death [159-163]. In summary, substantial evidence consistently indicates that reactive oxygen species (ROS) production, oxidative damage, and a dysregulation of the endogenous antioxidant system occur throughout gestation in different animal models of FASD and support the notion that oxidative stress is involved in the neuropathology of FASD.

EXPERIMENTAL TREATMENTS FOR FASD Research on the mechanisms involved in brain dysfunction observed in FASD has been mostly directed to the identification of interventions, such as therapeutics, dietary supplements, or enhancement of the environment. The last section of this chapter describes FASD treatments that are currently under investigation in preclinical and clinical settings. A substantial body of evidence derived from behavioral and neurochemical studies in rats supports the notion that choline deficiency during gestation negatively affects brain functions in the adult and aging brain. On the other hand, choline supplementation during gestation and neonatally improves memory performance and neuronal plasticity throughout life [164-166].

I.  NEURODEVELOPMENTAL DISORDERS

Experimental Treatments for FASD

57

FIGURE 3.2  Choline is metabolized to: (A) acetylcholine; this reaction occurs only in cholinergic neurons expressing choline acyltransferase; (B) the universal methyl donor S-adenosylmethionine; the enzymes catalyzing the first 2 steps of this pathway, the conversion of choline to betaine and the transfer of a methy group from betaine to methionine are present only in the liver and kidneys; (C) choline-containing phospholipids of which by far the most abundant is PC; the enzymes necessary for this pathway are expressed by all mammalian nucleated cells [167].

Multiple mechanisms have been hypothesized for these effects of choline. Choline is the precursor of phosphatidylcholine and sphingomyelin, two important membrane phospholipids, which also can generate second messengers, such as phosphatidic acid, diacylglycerol, and ceramide. Choline is also the precursor of two signaling lipids, platelet-activating factor and sphingosyphosphorylcholine. Choline can be oxidized to form betaine, a methyl donor, which may play a role in protein synthesis and in epigenetic DNA methylation. Finally, choline is the precursor of the neurotransmitter acetylcholine [168]. Choline’s main metabolic pathways are summarized in Figure 3.2. Recent evidence suggests that choline supplementation may also be effective in improving cognitive functions in two neurodevelopmental disorders characterized by mental retardation, Down syndrome [169] and Rett syndrome [170]. A series of studies have shown that prenatal and neonatal choline supplementation reduces hyperactivity and improves hippocampal-associated spatial learning deficits and cerebellarassociated behavioral abnormalities in the development of reflexes and motor coordination in rats exposed to ethanol during brain development [112,171-175]. However, the exact mechanisms by which choline exerts its protective effects remain elusive. A clinical trial for testing the effectiveness of choline treatments in FASD children is currently in progress [176]. Behavioral deficits resulting from prenatal or neonatal ethanol exposure in rodents can be improved by enhancement of the postnatal environment by neonatal handling [177], environmental enrichment [178], or complex motor training [179,180]. However, whether these enhancements can revert the neuroanatomical changes induced by ethanol remains controversial. Indeed, although enrichment does not rescue the reduction in dendritic spine density in rats exposed prenatally to alcohol [181], nor the reduction in cortical thickness in mice [182], a combination of voluntary exercise followed by living in a complex environment partially restores adult neurogenesis in the dentate gyrus while improving hippocampus-dependent behavior in animals neonatally exposed to alcohol [183]. An area of investigation that deserves further examination is whether social interactions impact behavioral outcomes differently in control and ethanol-exposed animals [37]. Based on some of the mechanisms targeted by ethanol during brain development, therapeutics that may prevent the effects of prenatal alcohol exposure are under investigation

I.  NEURODEVELOPMENTAL DISORDERS

58

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

in preclinical models. For instance, peptides that can antagonize ethanol-induced inhibition of L1 cell adhesion molecule have been tested in vitro and in vivo [184,185]; antioxidants, including superoxide dismutase [186], vitamin C [187], vitamin E [188], and green tea extract [189], have been shown to protect against ethanol-induced oxidative stress in FASD animal models. Serotonin agonists buspirone and ipsapirone were shown to protect against ethanolinduced serotoninergic neuron damage [190,191].

Acknowledgments This work was supported by grants AA017180 and AA021876 from the National Institute of Alcoholism and Alcohol Abuse. The author is extremely grateful to Dr. David Gavin for critically reading this chapter and to Mr. Jeff Frkonja for the graphic design of Figure 3.1.

References

[1] Streissguth AP, Landesman-Dwyer S, Martin JC, Smith DW. Teratogenic effects of alcohol in humans and laboratory animals. Science 1980;209:353–61. [2] Calhoun F, Warren K. Fetal alcohol syndrome: historical perspectives. Neurosci Biobehav Rev 2007;31:168–71. [3] Lemoine P, Harousseau H, Borteyru JP, Menuet JC. Children of alcoholic parents: abnormalities observed in 127 cases. Ouest Med 1968;8:476–82. [4] Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973;302:999–1001. [5] Jones KL, Smith DW. The fetal alcohol syndrome. Teratology 1975;12:1–10. [6] Jones KL, Smith DW, Ulleland CN, Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973;1:1267–71. [7] Flak AL, Su S, Bertrand J, Denny CH, Kesmodel US, Cogswell ME. The association of mild, moderate, and binge prenatal alcohol exposure and child neuropsychological outcomes: a meta-analysis. Alcohol Clin Exp Res 2014;38:214–26. [8] Bertrand J, Floyd RL, Weber MK, O’Connor M, Riley EP, Johnson KA, et al. Fetal alcohol syndrome: guidelines for referral and diagnosis. Atlanta (GA): Centers for Disease Control and Prevention; 2004. [9] Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA 2003;290:2996–9. [10] Hoyme HE, MPA KW, Kodituwakku P, Gossage JP, Trujillo PM, Buckley D, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine criteria. Pediatrics 2005;115:37–49. [11] Institute of Medicine (IOM), Howe CSK, Battaglia F, Committee to Study Fetal Alcohol Syndrome, Division of Biobehavioral Sciences and Mental Disorders. Fetal alcohol syndrome: diagnosis, epidemiology, prevention, and treatment. Washington (DC): National Academy Press; 1996. [12] Astley SJ. Diagnostic guide for fetal alcohol spectrum disroders: the 4-digit diagnostic code. Seattle: University of Washington Publication Service; 2004. [13] Lang J. Ten brain domains: a proposal for functional central nervous system parameters for fetal alcohol spectrum disorder diagnosis and follow-up. J FAS Inst 2006;4:1–11. [14] May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health 2001;25:159–67. [15] May PA, Gossage JP, Kalberg WO, Robinson LK, Buckley D, Manning M, et al. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev 2009;15:176–92. [16] May PA, Gossage JP, Marais AS, Adnams CM, Hoyme HE, Jones KL, et al. The epidemiology of fetal alcohol syndrome and partial FAS in a South African community. Drug Alcohol Depend 2007;88:259–71. [17] May PA, Gossage JP. Epidemiology of alcohol consumption among American Indians living in four reservations and in nearby border towns. Drug Alcohol Depend 2001;63:S100. [18] Riley EP, McGee CL. Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp Biol Med (Maywood) 2005;230:357–65.

I.  NEURODEVELOPMENTAL DISORDERS

References

59

[19] Mattson SN, Riley EP. A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin Exp Res 1998;22:279–94. [20] Abel EL, Sokol RJ. Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend 1987;19:51–70. [21] Streissguth AP, Barr HM, Kogan J, Bookstein FL. Primary and secondary disabilities. In: Streissguth AP, Kanter J, editors. Fetal alcohol syndrome in the challenge of fetal alcohol syndrome: overcoming secondary disabilities. Seattle (WA): University of Washington Press; 1997. p. 25–39. [22] Mattson SN, Riley EP, Gramling L, Delis DC, Jones KL. Heavy prenatal alcohol exposure with or without physical features of fetal alcohol syndrome leads to IQ deficits. J Pediatr 1997;131:718–21. [23] Howell KK, Lynch ME, Platzman KA, Smith GH, Coles CD. Prenatal alcohol exposure and ability, academic achievement, and school functioning in adolescence: a longitudinal follow-up. J Pediatr Psychol 2006;31:116–26. [24] Mattson SN, Roebuck TM. Acquisition and retention of verbal and nonverbal information in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res 2002;26:875–82. [25] Roebuck-Spencer TM, Mattson SN. Implicit strategy affects learning in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res 2004;28:1424–31. [26] Mattson SN, Gramling L, Delis D, Jones KL, Riley EP. Global-local processing in children prenatally exposed to alcohol. Child Neuropsychol 1996;2:165–75. [27] Coles CD, Platzman KA, Lynch ME, Freides D. Auditory and visual sustained attention in adolescents prenatally exposed to alcohol. Alcohol Clin Exp Res 2002;26:263–71. [28] Fryer SL, McGee CL, Matt GE, Riley EP, Mattson SN. Evaluation of psychopathological conditions in children with heavy prenatal alcohol exposure. Pediatrics 2007;119:e733–41. [29] Guerri C, Bazinet A, Riley EP. Foetal alcohol spectrum disorders and alterations in brain and behaviour. Alcohol Alcohol 2009;44:108–14. [30] Mattson SN, Crocker N, Nguyen TT. Fetal alcohol spectrum disorders: neuropsychological and behavioral features. Neuropsychol Rev 2011;21:81–101. [31] Cohen Jr MM, Shiota K. Teratogenesis of holoprosencephaly. Am J Med Genet 2002;109:1–15. [32] Lebel C, Roussotte F, Sowell ER. Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain. Neuropsychol Rev 2011;21:102–18. [33] Norman AL, Crocker N, Mattson SN, Riley EP. Neuroimaging and fetal alcohol spectrum disorders. Dev Disabil Res Rev 2009;15:209–17. [34] Joseph J, Warton C, Jacobson SW, Jacobson JL, Molteno CD, Eicher A, et al. Three-dimensional surface deformation-based shape analysis of hippocampus and caudate nucleus in children with fetal alcohol spectrum disorders. Hum Brain Mapp 2014;35:659–72. [35] Driscoll CD, Streissguth AP, Riley EP. Prenatal alcohol exposure: comparability of effects in humans and animal models. Neurotoxicol Teratol 1990;12:231–7. [36] Kelly SJ, Day N, Streissguth AP. Effects of prenatal alcohol exposure on social behavior in humans and other species. Neurotoxicol Teratol 2000;22:143–9. [37] Kelly SJ, Goodlett CR, Hannigan JH. Animal models of fetal alcohol spectrum disorders: impact of the social environment. Dev Disabil Res Rev 2009;15:200–8. [38] Bonthius DJ, West JR. Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure. Alcohol Clin Exp Res 1990;14:107–18. [39] Miller MW. Effects of alcohol on the generation and migration of cerebral cortical neurons. Science 1986;233:1308–11. [40] Miller MW. Exposure to ethanol during gastrulation alters somatosensory-motor cortices and the underlying white matter in the macaque. Cereb Cortex 2007;17:2961–71. [41] Miller MW, Potempa G. Numbers of neurons and glia in mature rat somatosensory cortex: effects of prenatal exposure to ethanol. J Comp Neurol 1990;293:92–102. [42] Miller MW, Robertson S. Prenatal exposure to ethanol alters the postnatal development and transformation of radial glia to astrocytes in the cortex. J Comp Neurol 1993;337:253–66. [43] Mooney SM, Miller MW. Nerve growth factor neuroprotection of ethanol-induced neuronal death in rat cerebral cortex is age dependent. Neuroscience 2007;149:372–81. [44] Berman RF, Hannigan JH. Effects of prenatal alcohol exposure on the hippocampus: spatial behavior, electrophysiology, and neuroanatomy. Hippocampus 2000;10:94–110.

I.  NEURODEVELOPMENTAL DISORDERS

60

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

[45] Guerri C. Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure. Alcohol Clin Exp Res 1998;22:304–12. [46] Luo J. Mechanisms of ethanol-induced death of cerebellar granule cells. Cerebellum 2012;11:145–54. [47] Creeley CE, Olney JW. Drug-induced apoptosis: mechanism by which alcohol and many other drugscan disrupt brain development. Brain Sci 2013;3:1153–81. [48] Deng J, Elberger AJ. Corpus callosum and visual cortex of mice with deletion of the NMDA-NR1 receptor. II. Attenuation of prenatal alcohol exposure effects. Brain Res Dev Brain Res 2003;144:135–50. [49] Livy DJ, Elberger AJ. Alcohol exposure during the first two trimesters-equivalent alters the development of corpus callosum projection neurons in the rat. Alcohol 2008;42:285–93. [50] Qiang M, Wang MW, Elberger AJ. Second trimester prenatal alcohol exposure alters development of rat corpus callosum. Neurotoxicol Teratol 2002;24:719–32. [51] Rice D, Barone Jr S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000;108(Suppl. 3):511–33. [52] Sulik KK. Genesis of alcohol-induced craniofacial dysmorphism. Exp Biol Med (Maywood) 2005;230:366–75. [53] Barnes DE, Walker DW. Prenatal ethanol exposure permanently reduces the number of pyramidal neurons in rat hippocampus. Brain Res 1981;227:333–40. [54] West JR, Hamre KM, Cassell MD. Effects of ethanol exposure during the third trimester equivalent on neuron number in rat hippocampus and dentate gyrus. Alcohol Clin Exp Res 1986;10:190–7. [55] Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000;287:1056–60. [56] Cui ZJ, Zhao KB, Zhao HJ, Yu DM, Niu YL, Zhang JS, et al. Prenatal alcohol exposure induces long-term changes in dendritic spines and synapses in the mouse visual cortex. Alcohol Alcohol 2010;45:312–9. [57] Davies DL, Smith DE. A Golgi study of mouse hippocampal CA1 pyramidal neurons following perinatal ethanol exposure. Neurosci Lett 1981;26:49–54. [58] Granato A, Di Rocco F, Zumbo A, Toesca A, Giannetti S. Organization of cortico-cortical associative projections in rats exposed to ethanol during early postnatal life. Brain Res Bull 2003;60:339–44. [59] Hamilton DA, Akers KG, Rice JP, Johnson TE, Candelaria-Cook FT, Maes LI, et al. Prenatal exposure to moderate levels of ethanol alters social behavior in adult rats: relationship to structural plasticity and immediate early gene expression in frontal cortex. Behav Brain Res 2010;207:290–304. [60] Hamilton GF, Whitcher LT, Klintsova AY. Postnatal binge-like alcohol exposure decreases dendritic complexity while increasing the density of mature spines in mPFC layer II/III pyramidal neurons. Synapse 2010;64:127–35. [61] Smith DE, Davies DL. Effect of perinatal administration of ethanol on the CA1 pyramidal cell of the hippocampus and Purkinje cell of the cerebellum: an ultrastructural survey. J Neurocytol 1990;19:708–17. [62] Melcer T, Gonzalez D, Barron S, Riley EP. Hyperactivity in preweanling rats following postnatal alcohol exposure. Alcohol 1994;11:41–5. [63] Cudd TA. Animal model systems for the study of alcohol teratology. Exp Biol Med (Maywood) 2005;230:389–93. [64] Smith SM. The avian embryo in fetal alcohol research. Methods Mol Biol 2008;447:75–84. [65] McClure KD, French RL, Heberlein UA. Drosophila model for fetal alcohol syndrome disorders: role for the insulin pathway. Dis Model Mech 2011;4:335–46. [66] Cole GJ, Zhang C, Ojiaku P, Bell V, Devkota S, Mukhopadhyay S. Effects of ethanol exposure on nervous system development in zebrafish. Int Rev Cell Mol Biol 2012;299:255–315. [67] Chasnoff IJ. Fetal alcohol syndrome in twin pregnancy. Acta Genet Med Gemellol (Roma) 1985;34:229–32. [68] Streissguth AP, Dehaene P. Fetal alcohol syndrome in twins of alcoholic mothers: concordance of diagnosis and IQ. Am J Med Genet 1993;47:857–61. [69] Das UG, Cronk CE, Martier SS, Simpson PM, McCarver DG. Alcohol dehydrogenase 2*3 affects alterations in offspring facial morphology associated with maternal ethanol intake in pregnancy. Alcohol Clin Exp Res 2004;28:1598–606. [70] Green RF, Stoler JM. Alcohol dehydrogenase 1B genotype and fetal alcohol syndrome: a HuGE minireview. Am J Obstet Gynecol 2007;197:12–25. [71] Jacobson SW, Carr LG, Croxford J, Sokol RJ, Li TK, Jacobson JL. Protective effects of the alcohol dehydrogenase-ADH1B allele in children exposed to alcohol during pregnancy. J Pediatr 2006;148:30–7. [72] McCarthy N, Eberhart JK. Gene-ethanol interactions underlying fetal alcohol spectrum disorders. Cell Mol Life Sci 2014;71:2699–706. [73] Dikranian K, Qin YQ, Labruyere J, Nemmers B, Olney JW. Ethanol-induced neuroapoptosis in the developing rodent cerebellum and related brain stem structures. Brain Res Dev Brain Res 2005;155:1–13. I.  NEURODEVELOPMENTAL DISORDERS

References

61

[74] Tenkova T, Young C, Dikranian K, Labruyere J, Olney JW. Ethanol-induced apoptosis in the developing visual system during synaptogenesis. Invest Ophthalmol Vis Sci 2003;44:2809–17. [75] Karacay B, Li S, Bonthius DJ. Maturation-dependent alcohol resistance in the developing mouse: cerebellar neuronal loss and gene expression during alcohol-vulnerable and -resistant periods. Alcohol Clin Exp Res 2008;32:1439–50. [76] Maier SE, Miller JA, Blackwell JM, West JR. Fetal alcohol exposure and temporal vulnerability: regional differences in cell loss as a function of the timing of binge-like alcohol exposure during brain development. Alcohol Clin Exp Res 1999;23:726–34. [77] Maier SE, West JR. Regional differences in cell loss associated with binge-like alcohol exposure during the first two trimesters equivalent in the rat. Alcohol 2001;23:49–57. [78] Napper RM, West JR. Permanent neuronal cell loss in the cerebellum of rats exposed to continuous low blood alcohol levels during the brain growth spurt: a stereological investigation. J Comp Neurol 1995;362:283–92. [79] Wozniak DF, Hartman RE, Boyle MP, Vogt SK, Brooks AR, Tenkova T, et al. Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol Dis 2004;17:403–14. [80] Dunty Jr WC, Chen SY, Zucker RM, Dehart DB, Sulik KK. Selective vulnerability of embryonic cell populations to ethanol-induced apoptosis: implications for alcohol-related birth defects and neurodevelopmental disorder. Alcohol Clin Exp Res 2001;25:1523–35. [81] Guerri C, Pascual M, Renau-Piqueras J. Glia and fetal alcohol syndrome. Neurotoxicology 2001;22:593–9. [82] Phillips DE, Krueger SK. Effects of combined pre- and postnatal ethanol exposure (three trimester equivalency) on glial cell development in rat optic nerve. Int J Dev Neurosci 1992;10:197–206. [83] Clarren SK, Alvord Jr EC, Sumi SM, Streissguth AP, Smith DW. Brain malformations related to prenatal exposure to ethanol. J Pediatr 1978;92:64–7. [84] Perez-Torrero E, Duran P, Granados L, Gutierez-Ospina G, Cintra L, Diaz-Cintra S. Effects of acute prenatal ethanol exposure on Bergmann glia cells early postnatal development. Brain Res 1997;746:305–8. [85] Riley EP, Mattson SN, Sowell ER, Jernigan TL, Sobel DF, Jones KL. Abnormalities of the corpus callosum in children prenatally exposed to alcohol. Alcohol Clin Exp Res 1995;19:1198–202. [86] Samson H. Microenchephaly and fetal alcohol syndrome: human and animal studies. In: West J, editor. Alcohol and brain development. Oxford: Oxford Press; 1986. p. 167–83. [87] Guizzetti M, Costa LG. Inhibition of muscarinic receptor-stimulated glial cell proliferation by ethanol. J Neurochem 1996;67:2236–45. [88] Kotter K, Klein J. Ethanol inhibits astroglial cell proliferation by disruption of phospholipase D-mediated signaling. J Neurochem 1999;73:2517–23. [89] Resnicoff M, Rubini M, Baserga R, Rubin R. Ethanol inhibits insulin-like growth factor-1-mediated signalling and proliferation of C6 rat glioblastoma cells. Lab Invest 1994;71:657–62. [90] Catlin MC, Guizzetti M, Costa LG. Effect of ethanol on muscarinic receptor-induced calcium responses in astroglia. J Neurosci Res 2000;60:345–55. [91] Guizzetti M, Costa LG. Muscarinic receptors, protein kinase C isozymes and proliferation of astroglial cells: effects of ethanol. Neurotoxicology 2000;21:1117–21. [92] Yagle K, Lu H, Guizzetti M, Moller T, Costa LG. Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: role in DNA synthesis and effect of ethanol. Glia 2001;35:111–20. [93] Guizzetti M, Bordi F, Dieguez-Acuna FJ, Vitalone A, Madia F, Woods JS, et al. Nuclear factor kappaB activation by muscarinic receptors in astroglial cells: effect of ethanol. Neuroscience 2003;120:941–50. [94] Guizzetti M, Costa LG. Possible role of protein kinase C ζ in muscarinic receptor-induced proliferation of astrocytoma cells. Biochem Pharmacol 2000;60:1457–66. [95] Guizzetti M, Thompson BD, Kim Y, VanDeMark K, Costa LG. Role of phospholipase D signaling in ethanol-induced inhibition of carbachol-stimulated DNA synthesis of 1321N1 astrocytoma cells. J Neurochem 2004;90:646–53. [96] Tsuji R, Guizzetti M, Costa LG. In vivo ethanol decreases phosphorylated MAPK and p70S6 kinase in the developing rat brain. Neuroreport 2003;14:1395–9. [97] Guizzetti M, Costa LG. Effect of ethanol on protein kinase C ζ and p70S6 kinase activation by carbachol: a possible mechanism for ethanol-induced inhibition of glial cell proliferation. J Neurochem 2002;82:38–46. [98] Klein J. Functions and pathophysiological roles of phospholipase D in the brain. J Neurochem 2005;94:1473–87. [99] Sowell ER, Johnson A, Kan E, Lu LH, Van Horn JD, Toga AW, et al. Mapping white matter integrity and neurobehavioral correlates in children with fetal alcohol spectrum disorders. J Neurosci 2008;28:1313–9. I.  NEURODEVELOPMENTAL DISORDERS

62

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

[100] Creeley CE, Dikranian KT, Johnson SA, Farber NB, Olney JW. Alcohol-induced apoptosis of oligodendrocytes in the fetal macaque brain. Acta Neuropathol Commun 2013;1:23. [101] Fernandez-Lizarbe S, Pascual M, Guerri C. Critical role of TLR4 response in the activation of microglia induced by ethanol. J Immunol 2009;183:4733–44. [102] Boyadjieva NI, Sarkar DK. Cyclic adenosine monophosphate and brain-derived neurotrophic factor decreased oxidative stress and apoptosis in developing hypothalamic neuronal cells: role of microglia. Alcohol Clin Exp Res 2013;37:1370–9. [103] Boyadjieva NI, Sarkar DK. Microglia play a role in ethanol-induced oxidative stress and apoptosis in developing hypothalamic neurons. Alcohol Clin Exp Res 2013;37:252–62. [104] Kane CJ, Phelan KD, Han L, Smith RR, Xie J, Douglas JC, et al. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptorgamma agonists. Brain Behav Immun 2011;25(Suppl. 1):S137–45. [105] Izumi Y, Kitabayashi R, Funatsu M, Izumi M, Yuede C, Hartman RE, et al. A single day of ethanol exposure during development has persistent effects on bi-directional plasticity, N-methyl-D-aspartate receptor function and ethanol sensitivity. Neuroscience 2005;136:269–79. [106] Richardson DP, Byrnes ML, Brien JF, Reynolds JN, Dringenberg HC. Impaired acquisition in the water maze and hippocampal long-term potentiation after chronic prenatal ethanol exposure in the guinea-pig. Eur J Neurosci 2002;16:1593–8. [107] Servais L, Hourez R, Bearzatto B, Gall D, Schiffmann SN, Cheron G. Purkinje cell dysfunction and alteration of long-term synaptic plasticity in fetal alcohol syndrome. Proc Natl Acad Sci USA 2007;104:9858–63. [108] Sutherland RJ, McDonald RJ, Savage DD. Prenatal exposure to moderate levels of ethanol can have longlasting effects on hippocampal synaptic plasticity in adult offspring. Hippocampus 1997;7:232–8. [109] Clements KM, Girard TA, Ellard CG, Wainwright PE. Short-term memory impairment and reduced hippocampal c-Fos expression in an animal model of fetal alcohol syndrome. Alcohol Clin Exp Res 2005;29:1049–59. [110] Girard TA, Xing HC, Ward GR, Wainwright PE. Early postnatal ethanol exposure has long-term effects on the performance of male rats in a delayed matching-to-place task in the Morris water maze. Alcohol Clin Exp Res 2000;24:300–6. [111] Goodlett CR, Johnson TB. Neonatal binge ethanol exposure using intubation: timing and dose effects on place learning. Neurotoxicol Teratol 1997;19:435–46. [112] Thomas JD, Biane JS, O’Bryan KA, O’Neill TM, Dominguez HD. Choline supplementation following third-trimester-equivalent alcohol exposure attenuates behavioral alterations in rats. Behav Neurosci 2007;121:120–30. [113] Rema V, Ebner FF. Effect of enriched environment rearing on impairments in cortical excitability and plasticity after prenatal alcohol exposure. J Neurosci 1999;19:10993–1006. [114] Medina AE, Krahe TE, Coppola DM, Ramoa AS. Neonatal alcohol exposure induces long-lasting impairment of visual cortical plasticity in ferrets. J Neurosci 2003;23:10002–12. [115] Medina AE, Ramoa AS. Early alcohol exposure impairs ocular dominance plasticity throughout the critical period. Brain Res Dev Brain Res 2005;157:107–11. [116] Johnson TB, Stanton ME, Goodlett CR, Cudd TA. Eyeblink classical conditioning in the preweanling lamb. Behav Neurosci 2008;122:722–9. [117] Stanton ME, Goodlett CR. Neonatal ethanol exposure impairs eyeblink conditioning in weanling rats. Alcohol Clin Exp Res 1998;22:270–5. [118] Chappell TD, Margret CP, Li CX, Waters RS. Long-term effects of prenatal alcohol exposure on the size of the whisker representation in juvenile and adult rat barrel cortex. Alcohol 2007;41:239–51. [119] Margret CP, Chappell TD, Li CX, Jan TA, Matta SG, Elberger AJ, et al. Prenatal alcohol exposure (PAE) reduces the size of the forepaw representation in forepaw barrel subfield (FBS) cortex in neonatal rats: relationship between periphery and central representation. Exp Brain Res 2006;172:387–96. [120] Medina AE, Krahe TE, Ramoa AS. Early alcohol exposure induces persistent alteration of cortical columnar organization and reduced orientation selectivity in the visual cortex. J Neurophysiol 2005;93:1317–25. [121] Bearer CF, Swick AR, O’Riordan MA, Cheng G. Ethanol inhibits L1-mediated neurite outgrowth in postnatal rat cerebellar granule cells. J Biol Chem 1999;274:13264–70. [122] Littner Y, Tang N, He M, Bearer CF. L1 cell adhesion molecule signaling is inhibited by ethanol in vivo. Alcohol Clin Exp Res 2013;37:383–9. [123] Yanni PA, Lindsley TA. Ethanol inhibits development of dendrites and synapses in rat hippocampal pyramidal neuron cultures. Brain Res Dev Brain Res 2000;120:233–43. I.  NEURODEVELOPMENTAL DISORDERS

References

63

[124] Yanni PA, Rising LJ, Ingraham CA, Lindsley TA. Astrocyte-derived factors modulate the inhibitory effect of ethanol on dendritic development. Glia 2002;38:292–302. [125] Yeaney NK, He M, Tang N, Malouf AT, O’Riordan MA, Lemmon V, et al. Ethanol inhibits L1 cell adhesion molecule tyrosine phosphorylation and dephosphorylation and activation of pp60(src). J Neurochem 2009;110:779–90. [126] Chen S, Charness ME. Ethanol disrupts axon outgrowth stimulated by netrin-1, GDNF, and L1 by blocking their convergent activation of Src family kinase signaling. J Neurochem 2012;123:602–12. [127] Dou X, Wilkemeyer MF, Menkari CE, Parnell SE, Sulik KK, Charness ME. Mitogen-activated protein kinase modulates ethanol inhibition of cell adhesion mediated by the L1 neural cell adhesion molecule. Proc Natl Acad Sci USA 2013;110:5683–8. [128] Pascual M, Guerri C. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. J Neurochem 2007;103:557–68. [129] Chen S, Charness ME. Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling. Proc Natl Acad Sci USA 2008;105:19962–7. [130] Guizzetti M, Moore NH, Giordano G, Costa LG. Modulation of neuritogenesis by astrocyte muscarinic receptors. J Biol Chem 2008;283:31884–97. [131] Guizzetti M, Moore NH, Giordano G, VanDeMark KL, Costa LG. Ethanol inhibits neuritogenesis induced by astrocyte muscarinic receptors. Glia 2010;58:1395–406. [132] Zhang X, Bhattacharyya S, Kusumo H, Goodlett CR, Tobacman JK, Guizzetti M. Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol. Glia 2014;62:259–71. [133] Zhang X, Kusumo H, Sakharkar AJ, Pandey SC, Guizzetti M. Regulation of DNA methylation by ethanol induces tissue plasminogen activator expression in astrocytes. J Neurochem 2014;128:344–9. [134] Portoles M, Sanchis R, Guerri C. Thyroid hormone levels in rats exposed to alcohol during development. Horm Metab Res 1988;20:267–70. [135] Wilcoxon JS, Redei EE. Prenatal programming of adult thyroid function by alcohol and thyroid hormones. Am J Physiol Endocrinol Metab 2004;287:E318–26. [136] Hellemans KG, Sliwowska JH, Verma P, Weinberg J. Prenatal alcohol exposure: fetal programming and later life vulnerability to stress, depression and anxiety disorders. Neurosci Biobehav Rev 2010;34:791–807. [137] Weinberg J, Sliwowska JH, Lan N, Hellemans KG. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome. J Neuroendocrinol 2008;20:470–88. [138] Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457–63. [139] Zhou FC, Chen Y, Love A. Cellular DNA methylation program during neurulation and its alteration by alcohol exposure. Birth Defects Res A Clin Mol Teratol 2011;91:703–15. [140] Liu Y, Balaraman Y, Wang G, Nephew KP, Zhou FC. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics 2009;4:500–11. [141] Zhou FC, Balaraman Y, Teng M, Liu Y, Singh RP, Nephew KP. Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiation. Alcohol Clin Exp Res 2011;35:735–46. [142] Bekdash RA, Zhang C, Sarkar DK. Gestational choline supplementation normalized fetal alcohol-induced alterations in histone modifications, DNA methylation, and proopiomelanocortin (POMC) gene expression in beta-endorphin-producing POMC neurons of the hypothalamus. Alcohol Clin Exp Res 2013;37:1133–42. [143] Otero NK, Thomas JD, Saski CA, Xia X, Kelly SJ. Choline supplementation and DNA methylation in the hippocampus and prefrontal cortex of rats exposed to alcohol during development. Alcohol Clin Exp Res 2012;36:1701–9. [144] Perkins A, Lehmann C, Lawrence RC, Kelly SJ. Alcohol exposure during development: impact on the epigenome. Int J Dev Neurosci 2013;31:391–7. [145] Subbanna S, Shivakumar M, Umapathy NS, Saito M, Mohan PS, Kumar A, et al. G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain. Neurobiol Dis 2013;54:475–85. [146] Sathyan P, Golden HB, Miranda RC. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J Neurosci 2007;27:8546–57. [147] Pappalardo-Carter DL, Balaraman S, Sathyan P, Carter ES, Chen WJ, Miranda RC. Suppression and epigenetic regulation of MiR-9 contributes to ethanol teratology: evidence from zebrafish and murine fetal neural stem cell models. Alcohol Clin Exp Res 2013;37:1657–67. I.  NEURODEVELOPMENTAL DISORDERS

64

3.  FETAL ALCOHOL SPECTRUM DISORDERS (FASD)

[148] Tal TL, Franzosa JA, Tilton SC, Philbrick KA, Iwaniec UT, Turner RT, et al. MicroRNAs control neurobehavioral development and function in zebrafish. FASEB J 2012;26:1452–61. [149] Wang LL, Zhang Z, Li Q, Yang R, Pei X, Xu Y, et al. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod 2009;24:562–79. [150] Guo Y, Chen Y, Carreon S, Qiang M. Chronic intermittent ethanol exposure and its removal induce a different miRNA expression pattern in primary cortical neuronal cultures. Alcohol Clin Exp Res 2012;36:1058–66. [151] Balaraman S, Tingling JD, Tsai PC, Miranda RC. Dysregulation of microRNA expression and function contributes to the etiology of fetal alcohol spectrum disorders. Alcohol Res 2013;35:18–24. [152] Brocardo PS, Gil-Mohapel J, Christie BR. The role of oxidative stress in fetal alcohol spectrum disorders. Brain Res Rev 2011;67:209–25. [153] Chu J, Tong M, de la Monte SM. Chronic ethanol exposure causes mitochondrial dysfunction and oxidative stress in immature central nervous system neurons. Acta Neuropathol 2007;113:659–73. [154] Dembele K, Yao XH, Chen L, Nyomba BL. Intrauterine ethanol exposure results in hypothalamic oxidative stress and neuroendocrine alterations in adult rat offspring. Am J Physiol Regul Integr Comp Physiol 2006;291:R796–802. [155] Dong J, Sulik KK, Chen SY. The role of NOX enzymes in ethanol-induced oxidative stress and apoptosis in mouse embryos. Toxicol Lett 2010;193:94–100. [156] Ramachandran V, Perez A, Chen J, Senthil D, Schenker S, Henderson GI. In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: a potential role for 4-hydroxynonenal. Alcohol Clin Exp Res 2001;25:862–71. [157] Reyes E, Ott S, Robinson B. Effects of in utero administration of alcohol on glutathione levels in brain and liver. Alcohol Clin Exp Res 1993;17:877–81. [158] Patten AR, Brocardo PS, Sakiyama C, Wortman RC, Noonan A, Gil-Mohapel J, et al. Impairments in hippocampal synaptic plasticity following prenatal ethanol exposure are dependent on glutathione levels. Hippocampus 2013;23:1463–75. [159] Heaton MB, Paiva M, Madorsky I, Mayer J, Moore DB. Effects of ethanol on neurotrophic factors, apoptosisrelated proteins, endogenous antioxidants, and reactive oxygen species in neonatal striatum: relationship to periods of vulnerability. Brain Res Dev Brain Res 2003;140:237–52. [160] Heaton MB, Paiva M, Madorsky I, Shaw G. Ethanol effects on neonatal rat cortex: comparative analyses of neurotrophic factors, apoptosis-related proteins, and oxidative processes during vulnerable and resistant periods. Brain Res Dev Brain Res 2003;145:249–62. [161] Kumral A, Tugyan K, Gonenc S, Genc K, Genc S, Sonmez U, et al. Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res 2005;160:146–56. [162] Marino MD, Aksenov MY, Kelly SJ. Vitamin E protects against alcohol-induced cell loss and oxidative stress in the neonatal rat hippocampus. Int J Dev Neurosci 2004;22:363–77. [163] Smith AM, Zeve DR, Grisel JJ, Chen WJ. Neonatal alcohol exposure increases malondialdehyde (MDA) and glutathione (GSH) levels in the developing cerebellum. Brain Res Dev Brain Res 2005;160:231–8. [164] Li Q, Guo-Ross S, Lewis DV, Turner D, White AM, Wilson WA, et al. Dietary prenatal choline supplementation alters postnatal hippocampal structure and function. J Neurophysiol 2004;91:1545–55. [165] Meck WH, Williams CL, Cermak JM, Blusztajn J. Developmental periods of choline sensitivity provide an ontogenic mechanism for regulating memory capacity and age-related dementia. Front Integr Neurosci 2008;1:1–11. [166] Zeisel SH, Niculescu MD. Perinatal choline influences brain structure and function. Nutr Rev 2006;64:197–203. [167] Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res 2008;49:1187–94. [168] Blusztajn JK. Choline, a vital amine. Science 1998;281:794–5. [169] Moon J, Chen M, Gandhy SU, Strawderman M, Levitsky DA, Maclean KN, et al. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome. Behav Neurosci 2010;124:346–61. [170] Nag N, Berger-Sweeney JE. Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome. Neurobiol Dis 2007;26:473–80. [171] Thomas JD, Abou EJ, Dominguez HD. Prenatal choline supplementation mitigates the adverse effects of prenatal alcohol exposure on development in rats. Neurotoxicol Teratol 2009;31:303–11.

I.  NEURODEVELOPMENTAL DISORDERS

References

65

[172] Thomas JD, Garrison M, O’Neill TM. Perinatal choline supplementation attenuates behavioral alterations associated with neonatal alcohol exposure in rats. Neurotoxicol Teratol 2004;26:35–45. [173] Thomas JD, Idrus NM, Monk BR, Dominguez HD. Prenatal choline supplementation mitigates behavioral alterations associated with prenatal alcohol exposure in rats. Birth Defects Res A Clin Mol Teratol 2010;88:827–37. [174] Thomas JD, La Fiette MH, Quinn VR, Riley EP. Neonatal choline supplementation ameliorates the effects of prenatal alcohol exposure on a discrimination learning task in rats. Neurotoxicol Teratol 2000;22:703–11. [175] Thomas JD, Tran TD. Choline supplementation mitigates trace, but not delay, eyeblink conditioning deficits in rats exposed to alcohol during development. Hippocampus 2012;22:619–30. [176] Wozniak JR, Fuglestad AJ, Eckerle JK, Kroupina MG, Miller NC, Boys CJ, et al. Choline supplementation in children with fetal alcohol spectrum disorders has high feasibility and tolerability. Nutr Res 2013;33:897–904. [177] Weinberg J, Kim CK, Yu W. Early handling can attenuate adverse effects of fetal ethanol exposure. Alcohol 1995;12:317–27. [178] Hannigan JH, Berman RF, Zajac CS. Environmental enrichment and the behavioral effects of prenatal exposure to alcohol in rats. Neurotoxicol Teratol 1993;15:261–6. [179] Klintsova AY, Cowell RM, Swain RA, Napper RM, Goodlett CR, Greenough WT. Therapeutic effects of complex motor training on motor performance deficits induced by neonatal binge-like alcohol exposure in rats. I. Behavioral results. Brain Res 1998;800:48–61. [180] Klintsova AY, Scamra C, Hoffman M, Napper RM, Goodlett CR, Greenough WT. Therapeutic effects of complex motor training on motor performance deficits induced by neonatal binge-like alcohol exposure in rats: II. A quantitative stereological study of synaptic plasticity in female rat cerebellum. Brain Res 2002;937:83–93. [181] Berman RF, Hannigan JH, Sperry MA, Zajac CS. Prenatal alcohol exposure and the effects of environmental enrichment on hippocampal dendritic spine density. Alcohol 1996;13:209–16. [182] Wainwright PE, Levesque S, Krempulec L, Bulman-Fleming B, McCutcheon D. Effects of environmental enrichment on cortical depth and Morris-maze performance in B6D2F2 mice exposed prenatally to ethanol. Neurotoxicol Teratol 1993;15:11–20. [183] Hamilton GF, Jablonski SA, Schiffino FL, St Cyr SA, Stanton ME, Klintsova AY. Exercise and environment as an intervention for neonatal alcohol effects on hippocampal adult neurogenesis and learning. Neuroscience 2014;265:274–90. [184] Chen SY, Charness ME, Wilkemeyer MF, Sulik KK. Peptide-mediated protection from ethanol-induced neural tube defects. Dev Neurosci 2005;27:13–9. [185] Wilkemeyer MF, Chen SY, Menkari CE, Brenneman DE, Sulik KK, Charness ME. Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity. Proc Natl Acad Sci USA 2003;100:8543–8. [186] Kotch LE, Chen SY, Sulik KK. Ethanol-induced teratogenesis: free radical damage as a possible mechanism. Teratology 1995;52:128–36. [187] Peng Y, Kwok KH, Yang PH, Ng SS, Liu J, Wong OG, et al. Ascorbic acid inhibits ROS production, NF-kappa B activation and prevents ethanol-induced growth retardation and microencephaly. Neuropharmacology 2005;48:426–34. [188] Heaton MB, Mitchell JJ, Paiva M. Amelioration of ethanol-induced neurotoxicity in the neonatal rat central nervous system by antioxidant therapy. Alcohol Clin Exp Res 2000;24:512–8. [189] Long L, Li Y, Wang YD, He QY, Li M, Cai XD, et al. The preventive effect of oral EGCG in a fetal alcohol spectrum disorder mouse model. Alcohol Clin Exp Res 2010;34:1929–36. [190] Kim JA, Druse MJ. Protective effects of maternal buspirone treatment on serotonin reuptake sites in ethanolexposed offspring. Brain Res Dev Brain Res 1996;92:190–8. [191] Tajuddin NF, Druse MJ. In utero ethanol exposure decreased the density of serotonin neurons. Maternal ipsapirone treatment exerted a protective effect. Brain Res Dev Brain Res 1999;117:91–7.

I.  NEURODEVELOPMENTAL DISORDERS